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Comparison of spinal anesthesia
dosage based on height and
weight versus height alone
in patients undergoing elective
cesarean section

Khalid Maudood Siddiqui, Muhammad Asghar Ali, and Hameed Ullah
Department of Anesthesiology, Aga Khan University Hospital, Karachi, Pakistan

Background: Spinal anesthesia with bupivacaine, typically used for elective and emergency cesarean section, is associated with a significant incidence of hypotension resulting from sympathetic blockade. A variety of dosing regimens have
been used to administer spinal anesthesia for cesarean section. The objective of this study was to compare the incidence
of hypotension following two different fixed dosing regimens.
Methods: This was a randomized double-blind clinical trial with a two-sided design, 5% significance level and 80%
power. After approval of the hospital ethics review committee, 60 patients were divided randomly into two groups. In one
group, the local anesthetic dose was adjusted according to height and weight, and in the other, the dose was adjusted according to height only.
Results: Sixty women with a singleton pregnancy were included. Of the factors that could affect dose and blood pressure,
including age, weight, height, and dose, only height differed between the groups. Mean heart rate was similar between the
groups. Hypotension was significantly more frequent with dosage based on height alone than with two-factor dose calculation (56.7% vs. 26.7%; P = 0.018).
Conclusions: Adjusting the dose of isobaric bupivacaine to a patient’s height and weight provides adequate anesthesia for
elective cesarean section and is associated with a decreased incidence and severity of maternal hypotension and less use
of ephedrine.
Key Words: Caesarean section, Body height, Body weight, Local anesthetics, Spinal anesthesia.

Introduction
Corresponding author: Muhammad Asghar Ali, M.D.
Department of Anesthesiology, Aga Khan University Hospital, National
Stadium Road, Karachi 74800, Pakistan
Tel: 92-21-3486-4631, Fax: 92-21-3493-4294
E-mail: asghar.ashraf@aku.edu
Received: July 3, 2015.
Revised: 1st, September 5, 2015; 2nd, September 16, 2015.
Accepted: September 22, 2015.
Korean J Anesthesiol 2016 April 69(2): 143-148
http://dx.doi.org/10.4097/kjae.2016.69.2.143

Spinal anesthesia with bupivacaine is traditionally used in
combination with opioids for emergency and elective cesarean
section, and provides satisfactory outcomes. However, this strategy is associated with a significant incidence of hypotension resulting from sympathetic blockade [1-3]. Maternal hypotension
jeopardizes placental perfusion, compromises fetal outcome,
and can cause symptoms such as nausea, vomiting, and dizziness [4,5]. Many spinal anesthesia dosing regimes have been
described for cesarean section [6]; while a fixed dosing regimen
is preferred by some anesthetists, others adjust the dose based
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on patient characteristics. Adjusted dosing is supported by hemodynamic data showing that the time to attain a suitable sensory level for surgery correlates incrementally with height and is
inversely related to weight [7].
Previous studies have confirmed that the final level of the
block can be predicted by patient height and weight [8]. The optimal dose would allow dermatomal spread but avoid maternal
hypotension. In some studies, local anesthetic dose has been
adjusted with height alone [9]. However, whether height of the
block is related to patient height and weight or height only is
controversial. The purpose of this study was to determine the
best dosing regimen for adequate anesthesia with minimal side
effects.

Materials and Methods
This study was approved by the Ethics Review Committee
of Aga Khan University, and written informed consent was obtained from all patients included in the study. Sixty women with
singleton pregnancies and American Society of Anesthesiologists
physical status classifications I and II who were scheduled for
elective cesarean section were included. Women with a history
of pregnancy-induced hypertension, cardiovascular co-morbidities, known central nervous system disease, contraindications
to neuraxial block, weight < 50 kg or > 110 kg, height > 180
cm or < 140 cm, and allergy to local anesthetics were excluded.
Patients were randomized to the two groups using computergenerated codes sequentially allocated to sealed envelopes.
In the first patient group, the local anesthetic dose was adjusted according to height and weight (Table 1), whereas those
in the other group received a local anesthetic dose adjusted ac-

Table 1. Weight- and Height-adjusted 0.5% Bupivacaine Dosing Regimen
for Spinal Anesthesia in Women Undergoing cesarean Section
Patient
weight (kg)
50
55
60
65
70
75
80
85
90
95
100
105
110

Patient height (cm)
140

145

150

155

1.5
1.5
1.4
1.4
1.3

1.7
1.6
1.6
1.5
1.5
1.4
1.4

1.8
1.8
1.7
1.7
1.6
1.6
1.5
1.5
1.4

1.9
1.9
1.8
1.8
1.8
1.7
1.7
1.6
1.6
1.5
1.5

Values are milliliters.

144

160
2.0
2.0
1.9
1.9
1.9
1.8
1.8
1.7
1.7
1.7
1.6

165

170

2.1
2.1
2.0
2.0
2.0
1.9
1.9
1.8
1.8
1.7
1.7

2.2
2.2
2.1
2.1
2.1
2.0
2.0
1.9
1.9
1.8

175

180

cording to height only (Table 2). Patients were premedicated
with intravenous 50 mg ranitidine, 10 mg metoclopramide, and
30 ml oral sodium citrate 30 min before surgery.
Patients and researchers were blinded to group allocations.
The anesthetist who administered the neuraxial block was
unblinded. The drugs for each group were prepared in 3 ml syringes.
Our routine perioperative monitoring included continuous SpO2, electrocardiograph, and noninvasive blood pressure
monitoring. Hemodynamic variables were monitored every 5
min during surgery after spinal anesthesia was induced (Datex
Ohmeda AS, Helsinki, Finland). The level of sensory block was
assessed 5 min after administering the spinal anesthetic.
After infiltrating the skin with 2% lidocaine, intravenous
access was obtained with an 18 G or 16 G wide bore cannula
through which all patients were preloaded with a balanced crystalloid solution (10 ml/kg) over 10 min before inducing spinal
anesthesia. Aseptic measures were used when administering
drugs into the spine. Subarachnoid block was obtained with the
patient in the sitting position using a 25 G pencil point spinal
needle at the L2–3 vertebral inter space. After aspirating cerebrospinal fluid, patients in the first group received 25 µg fentanyl
(0.5 ml) in isobaric 0.5% bupivacaine determined according
to the dosing regimen described in Table 1, while those in the
other group received the same drug solution at 0.05 mg/cm (Table 2) over 5 seconds. Patients were immediately turned supine
and maintained in the wedge position to minimize aortocaval
compression. Supplemental oxygen at 4 L/min was given to all
patients via face mask.
The usual hemodynamic alterations after administration of
spinal anesthesia as described in the literature were anticipated
and considered, such as bradycardia, hypotension, nausea/
vomiting, and ineffective spinal anesthesia. Bradycardia (heart
rate < 60 /min) was treated with intravenous 0.5 mg atropine,
hypotension (> 20% decrease in baseline mean arterial pressure
[MAP] and heart rate) and nausea, vomiting or dizziness were
treated with intravenous 5 mg ephedrine.

Table 2. Bupivacaine Dose and Volume with Respect to Patient Height
2.3
2.3
2.2
2.2
2.2
2.1
2.1
2.0
2.0

2.4
2.4
2.3
2.3
2.3
2.2
2.2
2.2

Patient height (cm)

Dose (mg)

Dose (ml)

140
145
150
155
160
165
170
175
180

7.0
7.2
7.5
7.7
8.0
8.2
8.5
8.7
9.0

1.4
1.4
1.5
1.5
1.6
1.6
1.7
1.7
1.8
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Once the sensory block was determined to be effective, surgery was initiated when loss of cold and pinprick sensations in
response to ethyl chloride spray were observed bilaterally. A 10o
head-down tilt was employed to improve block height and address ineffective blockade as evaluated at 8 min. A mixture of
50 : 50 O2 : N2O was administered by face mask if discomfort
was reported by the patient during surgery. If discomfort persisted, two intravenous boluses of 50 µg fentanyl were administered. We converted to general anesthesia if these measures were
inadequate.
Sixty subjects (30 /group) needed to be included in the study
to achieve 80% power at a 5% level of significance to detect a
25% difference in the incidence of hypotension between groups.
The incidence of hypotension in two pilot study groups were
34% and 9%. All statistical analyses were performed using SPSS
version 19.0 (IBM Corp., Armonk, NY, USA). Means or medians and frequency/percentage were computed for quantitative
and qualitative observations, respectively. Quantitative variables
were compared by Mann–Whitney U-test and independent
samples t-test, while proportions were compared by chi-square
test, and median time to adequate spinal block was compared
using the median test. Changes in heart rate and MAP were detected using repeated-measures analysis of variance. A P value ≤
0.05 was considered significant.

Table 3. Patient Demographic Data
Variables
Age (yr)
Weight (kg)
Height (cm)
Dose

Height/weight dosing Height-only dosing
(n = 30)
(n = 30)
29.26 ± 8.84
72.4 ± 12.65
159.4 ± 5.73
159.5 [7]
8.39 ± 0.81

29.73 ± 6.99
75.31 ± 11.31
155.86 ± 6.40
157 [9]
8.29 ± 2.00

P value
0.52
0.35
0.027*
0.05†
0.45

Values are mean ± standard deviation and median [interquartile range].
*Significant at P < 0.05 by independent sample t-test. †Mann–Whitney
U-test.

Results
Sixty women with singleton pregnancies were analyzed.
Patients’ mean age was 29.50 ± 7.90 years (95% confidence interval [CI], 27.46–31.54), and mean weight and height were .86
± 11.98 kg (95% CI, 70.76–76.96) and 157 ± 6.286 cm (95% CI,
156.03−159.27), respectively. Age, weight, and spinal anesthetic
dose did not differ between the groups, but mean height did
(P = 0.027) (Table 3).
The comparison of height and time to adequate spinal block
between the groups is shown in Table 4. The block was performed at T4 in 24 patients (80%) in the group whose anesthesia was dosed based on height and weight and in 27 (90%) in
the group with dosages based on height alone. Median time to
achieve adequate block in the first group was significantly longer
than that for the second group (P = 0.005). However, block level
did not differ between groups.
Mean heart rate did not differ between groups but a significant
within-group difference was detected in mean heart rate (P < 0.05).
MAP was similar between groups up to 30 min; however, a significant within-group difference was observed (P = 0.05; Figs. 1
and 2).
Bradycardia occurred in one patient receiving an anesthesia
dose based on both factors. The incidence of hypotension was
significantly higher in the height-alone dosage group than in the
two-factor dosage group (56.7% vs. 26.7%; P = 0.018). More patients receiving height-calculated anesthesia were given ephedrine
than in the other group (53.3% vs. 30.6%, P = 0.02), and a large
median dose was administered (10.5 mg vs. 7.5 mg, P = 0.042).
Four patients with two-factor anesthesia dosage had episodes
of vomiting, whereas three such cases were observed in the other group (Fig. 3). None of the patients were converted to general
anesthesia due to inadequate subarachnoid block.
Mean time to effective block (min) did not differ between
the groups (Table 5). Patients receiving two-factor anesthesia
dosages tended to take a longer time to be discharged from the
recovery room than those in the other group. No differences in

Table 4. Comparison of Height and Time to Adequate Block between the Groups
Height/weight dosing
(n = 30)

Height of block*
n (%)
T3
T4
T5
T6
T10
Time to adequate block

0 (0%)
24 (80%)
4 (13.3%)
2 (6.7%)
0 (%)
-

Median time in minutes (IQR)
8 [6]
8 [53]
11 [0]
8 [5]

Height-only dosing
(n = 30)
n (%)

Median time in minutes (IQR)

1 (3.3%)
27 (90%)
1 (3.3%)
0 (0%)
1 (%)
-

5 [4]
5 [4]

Total
1 (1.7%)
51 (85%)
5 (8.3%)
2 (3.3%)
1 (1.7%)
0.005

Values are numbers (%) and medians [interquartile range]. *P = 0.472, Fisher’s exact test; and P < 0.01; median test applied.
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the 1 and 5 min fetal APGAR scores were observed between the
groups.
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Fig. 1. Comparison of mean heart rate between patients receiving
anesthesia dosages based on height and weight (n = 30, triangles, solid
line) and those whose dose was calculated based on height alone (n =
30, circles, dotted line). Error bars are 95% confidence intervals. No
difference was observed between groups but a significant difference was
observed from baseline *P < 0.05 in the height-weight group and †P < 0.05
in the height-alone group.
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Discussion
Spinal anesthesia is generally used during cesarean sections
because it keeps the mother conscious, decreases problems related to complex intubation and maternal aspiration pneumonitis,
and facilitates effective postoperative pain relief. However, spinal
anesthesia can cause hypotension [10,11], which leads to in
utero placental hypoperfusion and instigates a severe drop in intervillous blood flow with the possibility of fetal acidemia [12,13].
A wide range of spinal anesthesia dosing regimes has been used
during cesarean section [6]. A direct correlation with height and
an inverse correlation with weight have been suggested based
on pharmacodynamic data collected at the time to onset of an
adequate sensory level for surgery and has been validated by
clinical observations [14].
In this prospective, double-blind, randomized study, we compared two spinal anesthesia dosing regimes for cesarean section
based on either patient height plus weight or height alone. The
onset time for suitable sensory blockade was longer in the height
plus weight group, although it was associated with decreased
prevalence and acuteness of maternal hypotension and a lower
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Fig. 2. Comparison of mean arterial pressure (MAP) between patients
receiving anesthesia dosages based on height and weight (n = 30,
triangles, solid line) and those whose dose was calculated based on
height alone (n = 30, circles, dotted line). Error bars are 95% confidence
intervals. No difference was observed between the groups but a
significant difference was observed from baseline *P < 0.05 in the
height-weight group and †P < 0.05 in the height-alone group.

Percentage

Mean heart rate (beats/min)

Local spinal anesthetic dose

Group A
Group B

P = 0.01
56.7

40
26.7

30

P = 0.6
13.3
10

20
10

3.3

0
Bradycardia

Hypotension

Vomiting

Fig. 3. Comparison of complications between the groups.

Table 5. Comparisons of Hypotension Treatment, Time to Reverse Block, and Discharge from the Recovery Room
Height/weight dosing
(n = 30)
Hypotension treated with‡
Ephedrine
Fentanyl
N2O
Time to block reversal (min)†
Time to discharge from recovery room (min)†

8 (26.7%)
5 (16.7%)
2 (6.7%)
115 [21]
130 [21]

Height-only dosing
(n = 30)
16 (53.3%)
2 (6.7%)
0 (0%)
110 [11]
125 [11]

P value

0.03*
0.22
0.49
0.081
0.084

Values are numbers (%) and medians [interquartile range]. *P < 0.05. †Mann–Whitney U-test. ‡Chi-square test.
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ephedrine requirement. This group tended to spend more time
in the recovery room before discharge than the other group but
the difference was not statistically significant. Norris [14] reported
that height has no effect on hyperbaric spinal anesthesia. However, theoretically, hypotension severity should be affected by
the quantity and volume of local anesthetic agent used. Harten
et al. [15] reported that the incidence and severity of maternal
hypotension decrease after adjusting the dose of hyperbaric bupivacaine to the patient’s height and weight, which is comparable
with our results.
In contrast to other studies, Nagata et al. [16] of Japan and
Chung et al. [2] of Korea demonstrated that pregnant women
require less local anesthetic compared to their nonpregnant
counterparts and that a height-adjusted dosing regime avoids
the risk of maternal hypotension. However, height-based dosing
was not compared with that based on height plus weight in these
studies.
Our results suggest that adjusting the anesthetic dose to
height and weight improves the safety of spinal anesthesia. Although the incidence and acuteness of maternal hypotension
declined in the height and weight group, its association with
improved fetal outcome was not verified.
In addition, variables affecting the spread and duration of
regional anesthesia, including but not limited to basicity, total
dose, type of local anesthetic solution, injection site, and patient
positioning must be considered, as they may affect the final outcome. Although spinal anesthesia is effective and safe, all corroborative factors should be considered.
The highest incidence of hypotension in women undergoing cesarean section is observed under spinal anesthesia. Nonmodifiable risk factors include female sex, age > 50 years, body
mass index > 35 kg/m2, and the nature of the surgery. Two other
modifiable risk factors are high bupivacaine dose and a sensory
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block level ≥ T5 [17]. In this study, all variables were comparable, except patient height.
Anesthesia may need to be augmented with intravenous narcotics if sensory block is insufficient or if the surgeon encounters
an unexpected event that requires more time, increasing anesthesia duration. Many studies have shown that various additives,
such as morphine and fentanyl enhance the spread and duration of spinal block via multiple administration routes [18]. We
found no difference in the use of fentanyl between according to
anesthesia dosage calculation method.
The incidence of hypotension during spinal anesthesia for
cesarean section is as high as 80% despite fluid preloading, lateral uterine displacement, and use of vasopressor agents [19].
Preventing and managing hypotension related to spinal anesthesia remains a difficult issue, and no single approach is optimal. Intravenous ephedrine during spinal anesthesia in women
undergoing cesarean section decreases the incidence of nausea
and vomiting [20]. Current local obstetric anesthesia practices
are established on a fixed dose of bupivacaine for subarachnoid
block without narcotics, except at some urban hospitals where
fentanyl is available and perioperative hypotension and bradycardia are common. The deleterious effects of spinal anesthesia
during cesarean section are more profound when the spinal anesthesia dose is not calculated logically. In this study, less ephedrine was used when the spinal bupivacaine dose was calculated
in relation to patient height and weight, which decreased the
incidence of hypotension, nausea, and vomiting.
Thus, we conclude that the isobaric 0.5% bupivacaine dosing
regimen should be based on patient height and weight and that
25 µg fentanyl should be added to achieve adequate anesthesia
for cesarean sections while minimizing the untoward side effects
of maternal hypotension with reduced use of vasopressors.
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